List of works - Andreas Lundqvist

"Markers and function of human NK cells in normal and pathological conditions."

scientific article published on 01 March 2017

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells.

scientific article published on 21 May 2013

A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer.

scientific article published on August 2004

Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis

scientific article

Acoustic formation of multicellular tumor spheroids enabling on-chip functional and structural imaging

scientific article published on 01 August 2018

Activated monocytes augment TRAIL-mediated cytotoxicity by human NK cells through release of IFN-γ

scientific article published on 26 October 2012

Allogeneic hematopoietic cell transplantation as immunotherapy for solid tumors: current status and future directions

scientific article

Allogeneic tumor-dendritic cell fusion vaccines for generation of broad prostate cancer T-cell responses

scientific article

Biomembrane-affinity centrifugal analyses of solute interactions with membrane proteins

scientific article published on 01 August 1999

Bortezomib Treatment to Potentiate the Anti-tumor Immunity of Ex-vivo Expanded Adoptively Infused Autologous Natural Killer Cells

scientific article

Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: a novel method to potentiate natural killer cell tumor cytotoxicity

scientific article published on July 2006

Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells

scientific article published on 06 February 2009

CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo

scientific article

Cancer classification using the Immunoscore: a worldwide task force

scientific article

Chromatography on cells and biomolecular assemblies.

scientific article published on October 1997

Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells

scientific article

Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination

scientific article published on 11 July 2020

Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells

scientific article

Conversion between two cytochalasin B-binding states of the human GLUT1 glucose transporter

scientific article published on 01 December 2000

Correction to: Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma

scientific article published on 6 November 2017

Correlation between HLA-A2 gene frequency, latitude, ovarian and prostate cancer mortality rates.

scientific article

Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma

scientific article published on 24 August 2018

Cripto-1 vaccination elicits protective immunity against metastatic melanoma

scientific article published on 8 January 2016

Cutting edge: bortezomib-treated tumors sensitized to NK cell apoptosis paradoxically acquire resistance to antigen-specific T cells

scientific article

D-Glucose, forskolin and cytochalasin B affinities for the glucose transporter Glut1. Study of pH and reconstitution effects by biomembrane affinity chromatography

scientific article published on 01 July 1997

Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β.

scientific article

Development of a technology platform for large-scale clinical grade production of DC.

scientific article

Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSF.

scientific article

Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling

scientific article published on 11 April 2013

Effects of human plasma proteins on maturation of monocyte-derived dendritic cells.

scientific article

Effects of pH, salt and time on ligand binding properties of overexpressed melanocortin 4 receptor.

scientific article published in March 2004

Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists.

scientific article published on 10 June 2017

Evaluation of Breast Cancer and Melanoma Metastasis in Syngeneic Mouse Models

scientific article published on 01 January 2019

Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways

scientific article published on 14 October 2010

First International Meeting of the Thematic Centre for Immune Modulatory Therapies for Autoimmunity and Cancer (IMTAC) 13-14 June 2011, Ljusterö, Sweden.

scientific article published on 15 January 2012

Gap junction intercellular communications regulate NK cell activation and modulate NK cytotoxic capacity

scientific article published on 27 December 2013

Gene-modified dendritic cells for immunotherapy against cancer

scientific article

Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma

scientific article published on 19 September 2017

Glucose affinity for the glucose transporter Glut1 in native or reconstituted lipid bilayers. Temperature-dependence study by biomembrane affinity chromatography

scientific article published on 01 July 1997

HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines

scientific article published on February 2012

HLA-dependent tumour development: a role for tumour associate macrophages?

scientific article

Heat-shock proteins as activators of the innate immune system

scientific article published on 01 March 2002

Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells

scientific article published on 11 September 2014

IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.

scientific article published on 27 July 2016

Immobilization of human red cells in gel particles for chromatographic activity studies of the glucose transporter Glut1

scientific article published on 01 April 1997

Immobilized membrane vesicle or proteoliposome affinity chromatography. Frontal analysis of interactions of cytochalasin B and D-glucose with the human red cell glucose transporter

scientific article published on 01 September 1996

Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy

scientific article published on 30 November 2020

Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity

scientific article published on 06 June 2014

Inhibiton of tumor-derived prostaglandin-e2 prevents the induction of human myeloid-derived suppressor cells (MDSCs) and rescues anti-tumor immunity

Interleukin-15 potentiates human natural killer cells to resist tumor-induced suppression through mTOR-regulated metabolic control.

scientific article published on 4 November 2015

Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma

scientific article

Major histocompatibility complex-I expression on embryonic stem cell-derived vascular progenitor cells is critical for syngeneic transplant survival.

scientific article

Mature dendritic cells are protected from Fas/CD95-mediated apoptosis by upregulation of Bcl-X(L).

scientific article

Mature dendritic cells induce tumor-specific type 1 regulatory T cells

scientific article published in May 2005

Melanocortin 1 Receptor-derived peptides are efficiently recognized by cytotoxic T lymphocytes from melanoma patients

scientific article published on 12 October 2013

Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms

scientific article published on 30 April 2013

Natural killer cell immunotherapy for cancer: a new hope

scientific article published on January 2008

Nephrotic syndrome: an under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation

scientific article published in October 2005

Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis

scientific article published on 25 July 2015

Nonviral and viral gene transfer into different subsets of human dendritic cells yield comparable efficiency of transfection

scientific article published in November 2002

Opposing consequences of signaling through EGF family members: Escape from CTLs could be a bait for NK cells

scientific article

Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation

scientific article published in May 2006

Overexpression and functional characterisation of the human melanocortin 4 receptor in Sf9 cells.

scientific article

PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates

scientific article published on 28 August 2020

Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation

scientific article published in March 2005

Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib

scientific article published on 15 October 2008

Recombinant adenovirus vector activates and protects human monocyte-derived dendritic cells from apoptosis

scientific article published in September 2002

Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donors

scientific article published on 19 December 2006

Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells

scientific article

Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells

scientific article published in April 2008

Regulation of TRAIL-receptor expression by the ubiquitin-proteasome system.

scientific article

Stereotactic Ablative Radio Therapy (SABR) followed by immunotherapy a challenge for individualized treatment of metastatic solid tumours

scientific article published on 22 May 2012

Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors

scientific article published on 23 July 2019

Targeting the tumor microenvironment to improve natural killer cell-based immunotherapies: On being in the right place at the right time, with resilience.

scientific article published on 24 September 2015

The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment

scientific article published on 25 September 2018

Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker.

scientific article

Toxic effects of sorafenib when given early after allogeneic hematopoietic stem cell transplantation

scientific article published on October 2010

Treatment of relapsed blast-phase Philadelphia-chromosome-positive leukaemia after non-myeloablative stem-cell transplantation with donor lymphocytes and imatinib.

scientific article

Unlicensed natural born killers.

scientific article

Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer.

scientific article published on 14 June 2017

List of works by Andreas Lundqvist

"Markers and function of human NK cells in normal and pathological conditions."

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells.

A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer.

Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis

Acoustic formation of multicellular tumor spheroids enabling on-chip functional and structural imaging

Activated monocytes augment TRAIL-mediated cytotoxicity by human NK cells through release of IFN-γ

Allogeneic hematopoietic cell transplantation as immunotherapy for solid tumors: current status and future directions

Allogeneic tumor-dendritic cell fusion vaccines for generation of broad prostate cancer T-cell responses

Biomembrane-affinity centrifugal analyses of solute interactions with membrane proteins

Bortezomib Treatment to Potentiate the Anti-tumor Immunity of Ex-vivo Expanded Adoptively Infused Autologous Natural Killer Cells

Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: a novel method to potentiate natural killer cell tumor cytotoxicity

Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells

CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo

Cancer classification using the Immunoscore: a worldwide task force

Chromatography on cells and biomolecular assemblies.

Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells

Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination

Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells

Conversion between two cytochalasin B-binding states of the human GLUT1 glucose transporter

Correction to: Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma

Correlation between HLA-A2 gene frequency, latitude, ovarian and prostate cancer mortality rates.

Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma

Cripto-1 vaccination elicits protective immunity against metastatic melanoma

Cutting edge: bortezomib-treated tumors sensitized to NK cell apoptosis paradoxically acquire resistance to antigen-specific T cells

D-Glucose, forskolin and cytochalasin B affinities for the glucose transporter Glut1. Study of pH and reconstitution effects by biomembrane affinity chromatography

Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β.

Development of a technology platform for large-scale clinical grade production of DC.

Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSF.

Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling

Effects of human plasma proteins on maturation of monocyte-derived dendritic cells.

Effects of pH, salt and time on ligand binding properties of overexpressed melanocortin 4 receptor.

Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists.

Evaluation of Breast Cancer and Melanoma Metastasis in Syngeneic Mouse Models

Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways

First International Meeting of the Thematic Centre for Immune Modulatory Therapies for Autoimmunity and Cancer (IMTAC) 13-14 June 2011, Ljusterö, Sweden.

Gap junction intercellular communications regulate NK cell activation and modulate NK cytotoxic capacity

Gene-modified dendritic cells for immunotherapy against cancer

Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma

Glucose affinity for the glucose transporter Glut1 in native or reconstituted lipid bilayers. Temperature-dependence study by biomembrane affinity chromatography

HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines

HLA-dependent tumour development: a role for tumour associate macrophages?

Heat-shock proteins as activators of the innate immune system

Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2/5/6 and chemoattract NK cells

IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.

Immobilization of human red cells in gel particles for chromatographic activity studies of the glucose transporter Glut1

Immobilized membrane vesicle or proteoliposome affinity chromatography. Frontal analysis of interactions of cytochalasin B and D-glucose with the human red cell glucose transporter

Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy

Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity

Inhibiton of tumor-derived prostaglandin-e2 prevents the induction of human myeloid-derived suppressor cells (MDSCs) and rescues anti-tumor immunity

Interleukin-15 potentiates human natural killer cells to resist tumor-induced suppression through mTOR-regulated metabolic control.

Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma

Major histocompatibility complex-I expression on embryonic stem cell-derived vascular progenitor cells is critical for syngeneic transplant survival.

Mature dendritic cells are protected from Fas/CD95-mediated apoptosis by upregulation of Bcl-X(L).

Mature dendritic cells induce tumor-specific type 1 regulatory T cells

Melanocortin 1 Receptor-derived peptides are efficiently recognized by cytotoxic T lymphocytes from melanoma patients

Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms

Natural killer cell immunotherapy for cancer: a new hope

Nephrotic syndrome: an under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation

Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis

Nonviral and viral gene transfer into different subsets of human dendritic cells yield comparable efficiency of transfection

Opposing consequences of signaling through EGF family members: Escape from CTLs could be a bait for NK cells

Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation

Overexpression and functional characterisation of the human melanocortin 4 receptor in Sf9 cells.

PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates

Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation

Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib

Recombinant adenovirus vector activates and protects human monocyte-derived dendritic cells from apoptosis

Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donors

Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells

Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells

Regulation of TRAIL-receptor expression by the ubiquitin-proteasome system.

Stereotactic Ablative Radio Therapy (SABR) followed by immunotherapy a challenge for individualized treatment of metastatic solid tumours

Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors

Targeting the tumor microenvironment to improve natural killer cell-based immunotherapies: On being in the right place at the right time, with resilience.

The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment

Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker.

Toxic effects of sorafenib when given early after allogeneic hematopoietic stem cell transplantation

Treatment of relapsed blast-phase Philadelphia-chromosome-positive leukaemia after non-myeloablative stem-cell transplantation with donor lymphocytes and imatinib.